BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROV
3651
DELISTED
Urovant Sciences Ltd.
UROV
| $3.05M | ﹤0.01% |
310,106
+4,617
| +2% | +$44.3K |
|
|
ENLC
3652
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.97M | ﹤0.01% |
1,215,297
+206,022
| +20% | +$426K |
|
3653
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $2.95M | ﹤0.01% |
106,711
+106,603
| +98,706% | +$2.86M |
|
3654
Carlyle Secured Lending
CGBD
$766M
| $2.91M | ﹤0.01% |
339,299
+31,177
| +10% | +$243K |
|
|
OTIC
3655
DELISTED
Otonomy, Inc.
OTIC
| $2.91M | ﹤0.01% |
803,522
+9,666
| +1% | +$25.2K |
|
|
GDO
3656
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.3M
| $2.9M | ﹤0.01% |
+177,303
| New | +$2.79M |
|
3657
Exagen
XGN
$161M
| $2.9M | ﹤0.01% |
233,564
+70,543
| +43% | +$955K |
|
3658
Banco de Chile
BCH
$21B
| $2.88M | ﹤0.01% |
163,272
-13,901
| -8% | -$244K |
|
3659
Security National Financial
SNFCA
$243M
| $2.87M | ﹤0.01% |
584,224
+476,223
| +441% | +$2.06M |
|
3660
BlackRock TCP Capital
TCPC
$331M
| $2.85M | ﹤0.01% |
311,497
-14,394
| -4% | -$124K |
|
3661
Bain Capital Specialty
BCSF
$840M
| $2.84M | ﹤0.01% |
256,362
+21,611
| +9% | +$224K |
|
|
GRTX
3662
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $2.84M | ﹤0.01% |
397,177
+325,620
| +455% | +$3.46M |
|
|
IMVP
3663
Invesco India ETF
IMVP
$108M
| $2.82M | ﹤0.01% |
165,296
+54,896
| +50% | +$861K |
|
|
JPXN
3664
iShares JPX-Nikkei 400 ETF
JPXN
$139M
| $2.8M | ﹤0.01% |
47,172
+405
| +0.9% | +$23.2K |
|
3665
Pliant Therapeutics
PLRX
$64.4M
| $2.77M | ﹤0.01% |
+85,487
| New | +$2.27M |
|
3666
Bassett Furniture
BSET
$169M
| $2.74M | ﹤0.01% |
372,648
-486,486
| -57% | -$3.06M |
|
3667
Loop Industries
LOOP
$31.7M
| $2.74M | ﹤0.01% |
304,113
-28,263
| -9% | -$243K |
|
3668
Korea Electric Power
KEP
$15.7B
| $2.73M | ﹤0.01% |
342,429
-17,500
| -5% | -$152K |
|
|
OIBR.C
3669
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $2.72M | ﹤0.01% |
2,594,458
| – | – |
|
|
JAX
3670
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $2.72M | ﹤0.01% |
552,770
-565,721
| -51% | -$2.57M |
|
3671
Protara Therapeutics
TARA
$231M
| $2.71M | ﹤0.01% |
92,384
+91,674
| +12,912% | +$2.84M |
|
|
UXIN
3672
Uxin Ltd
UXIN
$257M
| $2.7M | ﹤0.01% |
+18,893
| New | +$2.83M |
|
|
DRD
3673
DRDGold
DRD
$2.05B
| $2.69M | ﹤0.01% |
+170,281
| New | +$1.68M |
|
3674
Value Line
VALU
$342M
| $2.69M | ﹤0.01% |
99,607
+510
| +0.5% | +$14.6K |
|
|
SEAC
3675
DELISTED
Seachange International Inc
SEAC
| $2.66M | ﹤0.01% |
88,127
+54,931
| +165% | +$2.57M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.